TLR4 and cancer: Furthermore, it has also been shown that Matrine increases SCFA levels in the gut and prevents intestinal damage through the Toll-like receptor 4 (TLR4)/NF-κB/mitogen-activated protein kinase (MAPK) signaling pathway, demonstrating its great potential as a potential therapeutic agent for the treatment of cancer (180).